291 related articles for article (PubMed ID: 21668476)
1. Impact of CRTC1/3-MAML2 fusions on histological classification and prognosis of mucoepidermoid carcinoma.
Okumura Y; Miyabe S; Nakayama T; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Histopathology; 2011 Jul; 59(1):90-7. PubMed ID: 21668476
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoepidermoid carcinoma: a molecular and clinicopathologic study of 101 cases.
Miyabe S; Okabe M; Nagatsuka H; Hasegawa Y; Inagaki A; Ijichi K; Nagai N; Eimoto T; Yokoi M; Shimozato K; Inagaki H
J Oral Maxillofac Surg; 2009 Jul; 67(7):1432-41. PubMed ID: 19531414
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
[TBL] [Abstract][Full Text] [Related]
4. A new type of MAML2 fusion in mucoepidermoid carcinoma.
Fehr A; Röser K; Heidorn K; Hallas C; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2008 Mar; 47(3):203-6. PubMed ID: 18050304
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of EGFR pathway gene mutations and CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma.
Morita M; Murase T; Okumura Y; Ueda K; Sakamoto Y; Masaki A; Kawakita D; Tada Y; Nibu KI; Shibuya Y; Inagaki H
Histopathology; 2020 Jun; 76(7):1013-1022. PubMed ID: 32129900
[TBL] [Abstract][Full Text] [Related]
6. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
Saade RE; Bell D; Garcia J; Roberts D; Weber R
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
[TBL] [Abstract][Full Text] [Related]
7. CRTC1-MAML2 and CRTC3-MAML2 fusions were not detected in metaplastic Warthin tumor and metaplastic pleomorphic adenoma of salivary glands.
Skálová A; Vanecek T; Simpson RH; Vazmitsel MA; Majewska H; Mukensnabl P; Hauer L; Andrle P; Hosticka L; Grossmann P; Michal M
Am J Surg Pathol; 2013 Nov; 37(11):1743-50. PubMed ID: 24121173
[TBL] [Abstract][Full Text] [Related]
8. A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma.
Fehr A; Meyer A; Heidorn K; Röser K; Löning T; Bullerdiek J
Genes Chromosomes Cancer; 2009 Sep; 48(9):777-85. PubMed ID: 19521953
[TBL] [Abstract][Full Text] [Related]
9. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
10. Expression of amphiregulin in mucoepidermoid carcinoma of the major salivary glands: a molecular and clinicopathological study.
Shinomiya H; Ito Y; Kubo M; Yonezawa K; Otsuki N; Iwae S; Inagaki H; Nibu KI
Hum Pathol; 2016 Nov; 57():37-44. PubMed ID: 27393417
[TBL] [Abstract][Full Text] [Related]
11. "Pancreatic Mucoepidermoid Carcinoma" Is not a Pancreatic Counterpart of CRTC1/3-MAML2 Fusion Gene-related Mucoepidermoid Carcinoma of the Salivary Gland, and May More Appropriately be Termed Pancreatic Adenosquamous Carcinoma With Mucoepidermoid Carcinoma-like Features.
Saeki K; Ohishi Y; Matsuda R; Mochidome N; Miyasaka Y; Yamamoto H; Koga Y; Maehara Y; Nakamura M; Oda Y
Am J Surg Pathol; 2018 Nov; 42(11):1419-1428. PubMed ID: 30138216
[TBL] [Abstract][Full Text] [Related]
12. HER2 and EGFR gene copy number alterations are predominant in high-grade salivary mucoepidermoid carcinoma irrespective of MAML2 fusion status.
Nakano T; Yamamoto H; Hashimoto K; Tamiya S; Shiratsuchi H; Nakashima T; Nishiyama K; Higaki Y; Komune S; Oda Y
Histopathology; 2013 Sep; 63(3):378-92. PubMed ID: 23855785
[TBL] [Abstract][Full Text] [Related]
13. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma.
Okabe M; Miyabe S; Nagatsuka H; Terada A; Hanai N; Yokoi M; Shimozato K; Eimoto T; Nakamura S; Nagai N; Hasegawa Y; Inagaki H
Clin Cancer Res; 2006 Jul; 12(13):3902-7. PubMed ID: 16818685
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of MAML2 gene split in mucoepidermoid carcinoma.
Noda H; Okumura Y; Nakayama T; Miyabe S; Fujiyoshi Y; Hattori H; Shimozato K; Inagaki H
Cancer Sci; 2013 Jan; 104(1):85-92. PubMed ID: 23035786
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.
Birkeland AC; Foltin SK; Michmerhuizen NL; Hoesli RC; Rosko AJ; Byrd S; Yanik M; Nor JE; Bradford CR; Prince ME; Carey TE; McHugh JB; Spector ME; Brenner JC
Oral Oncol; 2017 May; 68():5-8. PubMed ID: 28438292
[TBL] [Abstract][Full Text] [Related]
16. Salivary mucoepidermoid carcinoma: histological variants, grading systems, CRTC1/3-MAML2 fusions, and clinicopathological features.
Nakano S; Okumura Y; Murase T; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Kawakita D; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Histopathology; 2022 Mar; 80(4):729-735. PubMed ID: 34657306
[TBL] [Abstract][Full Text] [Related]
17. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
O'Neill ID
Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
[TBL] [Abstract][Full Text] [Related]
18. CRTC1-MAML2 gene fusion in mucoepidermoid carcinoma of the lacrimal gland.
Von Holstein SL; Fehr A; Heegaard S; Therkildsen MH; Stenman G
Oncol Rep; 2012 May; 27(5):1413-6. PubMed ID: 22323114
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of CRTC1/3-MAML2 fusions in salivary gland mucoepidermoid carcinoma: A multiinstitutional retrospective study.
Okumura Y; Nakano S; Murase T; Ueda K; Kawakita D; Nagao T; Kusafuka K; Urano M; Yamamoto H; Kano S; Tsukahara K; Okami K; Nagao T; Hanai N; Iwai H; Kawata R; Tada Y; Nibu KI; Inagaki H
Cancer Sci; 2020 Nov; 111(11):4195-4204. PubMed ID: 32860299
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
